Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chenqiao Ye"'
Publikováno v:
Cell Death and Disease, Vol 12, Iss 11, Pp 1-11 (2021)
Abstract Cetuximab is approved for the treatment of metastatic colorectal cancer (mCRC) with RAS wild-type. Nevertheless, the prognosis remains poor and the effectiveness of cetuximab is limited in KRAS mutant mCRC. Recently, emerging evidence has sh
Externí odkaz:
https://doaj.org/article/c2181e41f0cc462294e76d04f119e6f0
Autor:
Lin Xu, Siqi Xie, Qinqing Qian, Zhiqiu Ye, Jiamin Chen, Xiaoxiao Fei, Yuan Chen, Na Ran, Mingsheng Hou, Chenqiao Ye, Zhangsen Yu, Mingliao Zhu
Publikováno v:
The Journal of Toxicological Sciences. 44:621-632
In the past few decades, upconversion nanoparticles (abbreviated as UCNPs) have been more widely applied in the biomedical fields, such as in vitro and in vivo upconversion fluorescent bioimaging, photodynamic therapy, biological macromolecular detec
Autor:
Chenqiao Ye, Guiying Xing, Yilan Xu, Zhenbo Lu, Zhangsen Yu, Feng Qiang, Na Ran, Qinqing Qian, Yun Zhang, Jinqing Tu, Yuan Chen
Publikováno v:
Journal of applied toxicology : JATREFERENCES. 41(6)
Cerium oxide (CeO2 ) nanoparticles have unique redox properties and exert excellent antioxidant effects in the biological environment. In recent years, many researchers have focused on the CeO2 nanoparticles as an effective antioxidant drug in the pr
Autor:
Yuan Chen1, Xiaoxiao Fei2, Chenqiao Ye1, Qinqing Qian1, Zhiqiu Ye1, Siqi Xie1, Jiamin Chen1, Mingliao Zhu1, Na Ran1, Mingsheng Hou3, Lin Xu4, Zhangsen Yu1 yzs@usx.edu.cn
Publikováno v:
Journal of Toxicological Sciences. 2019, Vol. 44 Issue 9, p621-632. 12p.